ctrl K

Price Alert

Atara Biotherapeutics Inc... (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

12.24

0.52 (4.44%)

At close: Aug 15, 2025, 3:59 PM

12.74

4.08%

After-hours: Aug 15, 2025, 07:47 PM EDT

Atara Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.03M	25.84M	92.94M	106.08M
Short-Term Investments	17.47M	25.88M	149.88M	264.98M
Long-Term Investments	n/a	n/a	n/a	1.2M
Other Long-Term Assets	3.1M	4.84M	7.02M	2.37M
Receivables	1.48M	34.11M	40.22M	986K
Inventory	10.65M	9.71M	1.59M	n/a
Other Current Assets	10.26M	6.33M	10.45M	194K
Total Current Assets	64.89M	101.87M	295.08M	384.62M
Property-Plant & Equipment	41.1M	58.79M	74.32M	79.94M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	44.2M	63.63M	81.34M	83.51M
Total Assets	109.1M	165.5M	376.42M	468.13M
Account Payables	4.37M	3.68M	6.87M	17.37M
Deferred Revenue	95.09M	77.83M	8M	40.76M
Short-Term Debt	13.92M	n/a	n/a	n/a
Other Current Liabilities	-7.33M	37.01M	32.75M	19.75M
Total Current Liabilities	134.57M	142.23M	78.92M	105.79M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	41.89M	39.25M	35.8M	1.5M
Total Long-Term Liabilities	71.81M	122.51M	170.86M	82.73M
Total Liabilities	206.38M	264.74M	249.78M	188.51M
Total Debt	43.83M	57.87M	71.7M	28.27M
Common Stock	1K	11K	10K	9K
Retained Earnings	-2.05B	-1.97B	-1.69B	-1.46B
Comprehensive Income	8K	-204K	-2.07M	-368K
Shareholders Equity	-97.28M	-99.23M	126.64M	279.61M
Total Investments	17.47M	25.88M	149.88M	264.98M